Track topics on Twitter Track topics that are important to you
Technavio’s global aluminum hydroxide market research report forecasts the market to grow at a CAGR of over 5% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181228005172/en/
Technavio predicts the global aluminum hydroxide market to grow at a CAGR of over 5% by 2022. (Graphic: Business Wire)
The consolidation of the market by mergers and acquisitions will be one of the major trends in the global aluminum hydroxide marketduring 2018-2022. The global aluminum hydroxide market underwent rapid consolidation through mergers and acquisitions in recent years. This has led to an increased focus on technology. For instance, on February 1, 2016, Huber Engineered Materials acquired Martinswerk of Albemarle Corporation.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
According to Technavio analysts, one of the key drivers for the global aluminum hydroxide market is the increasing demand for antacids:
Global aluminum hydroxide market: Increasing demand for antacids
GERD is a chronic condition, which is caused by the backflow of stomach contents such as gastric acid, into the esophagus. Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They offer quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and indigestion.
According to a senior research analyst at Technavio, “The treatment by antacids is symptomatic and is usually recommended for minor symptoms. Some of the frequently used antacids include aluminum hydroxide, magnesium carbonate, and magnesium trisilicate. Aluminum hydroxide gel powder is one of the antacids that is used in pharmaceutical preparation.”
Global aluminum hydroxide market: Segmentation analysis
This global aluminum hydroxide market analysis report provides market segmentation by application (chemical, flame retardant, filler, antacid, and others) and by region (the Americas, APAC, and EMEA). This report provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The APAC region held the largest share of the market in 2017, accounting for around 46% share. It was followed by the Americas and EMEA respectively. The APAC region is expected to dominate the market throughout the period 2018-2022.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...